These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20899)

  • 1. [Determination of the KM-value of the fumarase (E.C. 4.2.1.2) with bencyclan-hydrogenfumarate as the substrate (author's transl)].
    Korte I; Hockwin O; Ohrloff C; Schmidt G; Fuss R
    Arzneimittelforschung; 1977; 27(8):1532-4. PubMed ID: 20899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of bencyclane-hydrogen-fumarate on the carbohydrate metabolism of bovine lens homogenates.
    Hockwin O; Korte I; Loth C; Ohrloff C; Fuss R; Schmidt G
    Arzneimittelforschung; 1977 Jul; 27(7):1417-20. PubMed ID: 578465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of fludilat on carbohydrate metabolism].
    Hockwin O
    Fortschr Med; 1977 Aug; 95(29):1837-40. PubMed ID: 885465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)].
    Jäger W; Scharrer I; Satkowski U; Breddin K
    Arzneimittelforschung; 1975; 25(12):1938-44. PubMed ID: 1243666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro incubation of lenses. Model for testing substrate utilization of substances of the energy metabolism, demonstrated with bencyclane-hydrogen-fumarate (author's transl)].
    Hockwin O; Korte I; Breuer R; Schmidt G; Rast-Czyborra F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Aug; 207(3):169-80. PubMed ID: 309736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Decrease of disaccharidase activity following application of bencyclan-hydrogenfumarate (author's transl)].
    Frisius H; Al-Abadi H; Heidrich H
    Klin Wochenschr; 1976 Sep; 54(18):895-7. PubMed ID: 966636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood circulation, oxygen pressure and pH of the cerebral cortex under the influence of bencyclane].
    Gärtner E; Enzenross HG; Vlahov V; Schanzenbächer P; Brandt H; Betz E
    Arzneimittelforschung; 1975 Jun; 25(6):887-91. PubMed ID: 240368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetics of fumarate hydratase reaction catalyzed by free cells of Escherichia coli].
    Gubnitskiĭ LS; Margolin AL; Belousov AS; Iakovleva VI; Barezii IV
    Biokhimiia; 1981 Feb; 46(2):346-81. PubMed ID: 7018596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of bencyclane hydrogen fumarate (Fludilate) on the adhesion of tumor cells in vivo and in vitro].
    Schumann J
    Fortschr Med; 1976 Sep; 94(26):1429-32. PubMed ID: 61934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of bencyclan on shear induced platelet aggregation (author's transl)].
    Klose HJ; Rieger H; Schmid-Schönbein H
    Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bencyclane fumarate on brain metabolism in the rat--in vitro study].
    Cavallini L; Lucchetti G
    Boll Chim Farm; 1977 Aug; 116(8):473-83. PubMed ID: 921852
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].
    Krähenbühl B
    Schweiz Rundsch Med Prax; 1975 May; 64(20):632-4. PubMed ID: 1099573
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effects of elevated calcium concentrations in artificial cerebrospinal fluid on pial arteries during perivascular microperfusion and the Ca++-antagonistic effect of bencyclane (author's transl)].
    Brandt H; Schanzenbächer P; Enzenross HG; Betz E
    Arzneimittelforschung; 1975 Sep; 25(9):1393-6. PubMed ID: 1242660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial kinetic and mechanistic characterization of Escherichia coli fumarase A.
    Flint DH
    Arch Biochem Biophys; 1994 Jun; 311(2):509-16. PubMed ID: 8203917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bencyclan (Fludilat) in the treatment of patients with ischaemic cerebral infarction (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1976 Sep; 71(39):1611-6. PubMed ID: 790129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiodepressive action of bencyclan (author's transl)].
    Köhler E; Motzer S; Greff K
    Res Exp Med (Berl); 1975 Jul; 165(2):111-25. PubMed ID: 1224033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bencyclan's effects "in vitro" on fibrinolysis (author's transl)].
    Bucci M; Faggiani L; Formichi R; Paoli L
    Quad Sclavo Diagn; 1977 Dec; 13(4):478-81. PubMed ID: 614608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A contribution to the pharmacokinetics of bencyclane (Fludilat) in man.
    Bock PR
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):246-52. PubMed ID: 965131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumaric acid overproduction in yeast mutants deficient in fumarase.
    Kaclíková E; Lachowicz TM; Gbelská Y; Subík J
    FEMS Microbiol Lett; 1992 Mar; 70(2):101-6. PubMed ID: 1587456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How fumarase recycles after the malate --> fumarate reaction. Insights into the reaction mechanism.
    Rose IA
    Biochemistry; 1998 Dec; 37(51):17651-8. PubMed ID: 9922130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.